Fingerprint
Dive into the research topics of 'Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
H. Park, G. I. Shapiro, X. Gao, A. Mahipal, J. Starr, M. Furqan, P. Singh, A. Ahrorov, L. Gandhi, A. Ghosh, D. Hickman, P. D. Gallacher, A. Wennborg, E. C. Attar, M. M. Awad, S. Das, E. E. Dumbrava
Research output: Contribution to journal › Article › peer-review